SciClone Pharmaceuticals (SCLN +5.8%) gets a big boost today from an upgrade to Buy from Hold at...

|About: SciClone Pharmaceuticals, Inc. (SCLN)|By:, SA News Editor

SciClone Pharmaceuticals (SCLN +5.8%) gets a big boost today from an upgrade to Buy from Hold at Aegis Capital. The firm also set a $9 price target. The stock has had a solid run recently, gaining 12% over the past week.